(90 days)
Not Found
No
The device description and performance studies focus on mechanical and material properties, with no mention of AI/ML terms or functionalities.
No.
The device is used for introducing a drainage catheter, not for providing therapy itself. It acts as an introducer for another device.
No
Explanation: The device is a suprapubic introducer, which is an instrument used to insert a drainage catheter (a therapeutic intervention). It is not described as analyzing or interpreting biological signals or images for diagnostic purposes.
No
The device description explicitly lists physical components made of stainless steel and other materials (trocar stylet needle, dilator, peel-away sheath) and describes their physical dimensions and design. This indicates a hardware-based medical device, not a software-only one.
Based on the provided information, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- Intended Use: The intended use is to introduce a drainage catheter into the bladder suprapubically. This is a surgical or procedural intervention, not a diagnostic test performed on a sample taken from the body.
- Device Description: The device is a physical instrument (trocar, dilator, sheath) used for a procedural purpose. It does not involve the analysis of biological samples.
- Lack of IVD Characteristics: There is no mention of analyzing blood, urine, tissue, or any other biological sample for diagnostic purposes. The device's function is purely mechanical for accessing an anatomical site.
IVD devices are used to examine specimens derived from the human body to provide information for diagnostic, monitoring, or compatibility purposes. This device does not fit that description.
N/A
Intended Use / Indications for Use
The One-Step Suprapubic Introducer is used for introducing a drainage catheter suprapubically into the bladder.
Product codes (comma separated list FDA assigned to the subject device)
KOB
Device Description
The One-Step Suprapubic Introducer is comprised of a stainless steel trocar stylet needle and a dilator with a peel-away sheath. The trocar stylet needle is 20 centimeters (cm) long with a trocar beveled tip at the distal end of the device. The dilator is 14-22 French (Fr) and 18-19 cm in length. The peel-away sheath is 14-22 Fr and 17 cm in length. The three components are designed to fit together to form a single assembly.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
Bladder (suprapubically)
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Prescription Use (Part 21 CFR 801 Subpart D)
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
The subject device, the One-Step Suprapubic Introducer, was subjected to applicable testing to assure reliable design and performance under the testing parameters. The following tests have been conducted to ensure reliable design and performance under the specified testing parameters:
- Radiopacity Testing
- Peel-Away Shaft Tensile Test
- Dilator Shaft Tensile Test
- Peel Force
- Rollback Testing
- Dilator Hub-to-Shaft Tensile Test
- Dimensional Testing
- Biocompatibility Testing shows that the subject device conforms to the biocompatibility requirements based on its intended use. All evaluation criteria were met. The following biological effects were evaluated:
- Cytotoxicity
- Sensitization
- Irritation/Intracutaneous Reactivity
- Acute Systemic Toxicity
- Sterilization
- Package integrity and stability
- Shelf-life
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.
Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).
Not Found
§ 876.5090 Suprapubic urological catheter and accessories.
(a)
Identification. A suprapubic urological catheter and accessories is a flexible tubular device that is inserted through the abdominal wall into the urinary bladder with the aid of a trocar and cannula. The device is used to pass fluids to and from the urinary tract. This generic type of device includes the suprapubic catheter and tube, Malecot catheter, catheter punch instrument, suprapubic drainage tube, and the suprapubic cannula and trocar.(b)
Classification. (1) Class II (performance standards).(2) Class I for the catheter punch instrument, nondisposable cannula and trocar, and gastro-urological trocar. The devices subject to this paragraph (b)(2) are exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 876.9.
0
Image /page/0/Picture/0 description: The image shows the logo of the U.S. Food and Drug Administration (FDA). On the left is the Department of Health & Human Services logo. To the right of that is the FDA logo, which is a blue square with the letters "FDA" in white. To the right of the blue square is the text "U.S. FOOD & DRUG ADMINISTRATION" in blue.
December 26, 2018
Cook Incorporated Carly Powell Regulatory Affairs Specialist 750 Daniels Way Bloomington, Indiana 47404
Re: K182709
Trade/Device Name: One-Step Suprapubic Introducer Regulation Number: 21 CFR 876.5090 Regulation Name: Suprapubic Urological Catheter and Accessories Regulatory Class: Class II Product Code: KOB Dated: September 26, 2018 Received: September 27, 2018
Dear Carly Powell:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. Although this letter refers to your product as a device, please be aware that some cleared products may instead be combination products. The 510(k) Premarket Notification Database located at https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm identifies combination product submissions. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part
1
801); medical device reporting of medical device-related adverse events) (21 CFR 803) for devices or post-marketing safety reporting (21 CFR 4, Subpart B) for combination products (see https://www.fda.gov/CombinationProducts/GuidanceRegulatoryInformation/ucm597488.htm); good manufacturing practice requirements as set forth in the quality systems (OS) regulation (21 CFR Part 820) for devices or current good manufacturing practices (21 CFR 4, Subpart A) for combination products; and, if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm.
For comprehensive regulatory information about mediation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/MedicalDevices/DeviceRegulationandGuidance/) and CDRH Learn (http://www.fda.gov/Training/CDRHLearn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (http://www.fda.gov/DICE) for more information or contact DICE by email (DICE@fda.hhs.gov) or phone (1-800-638-2041 or 301-796-7100).
Sincerely,
Glenn B. Bell -S
for Benjamin R. Fisher, Ph.D. Director Division of Reproductive, Gastro-Renal, and Urological Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
2
Indications for Use
510(k) Number (if known)
Device Name One-Step Suprapubic Introducer
Indications for Use (Describe)
The One-Step Suprapubic Introducer is used for introducing a drainage catheter suprapubically into the bladder.
Type of Use (Select one or both, as applicable)
X Prescription Use (Part 21 CFR 801 Subpart D)
| Over-The-Counter Use (21 CFR 801 Subpart C)
CONTINUE ON A SEPARATE PAGE IF NEEDED.
This section applies only to requirements of the Paperwork Reduction Act of 1995.
DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.
The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:
Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff(@fda.hhs.gov
"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."
3
K182709 Page 1 of 3
Image /page/3/Picture/1 description: The image shows the logo for Cook Medical. The logo is a red rectangle with the word "COOK" in white, sans-serif font on the top half of the rectangle. Below the word "COOK" is the word "MEDICAL" in a smaller, white, sans-serif font. The bottom left corner of the rectangle is cut off at an angle.
COOK INCORPORATED 750 DANIELS WAY, P.O. BOX 489 BLOOMINGTON, IN 47402-0489 U.S.A 12.339.2235 TOLLESEE: 800.457.4 WWW.COOKMEDICAL.CO
One-Step Suprapubic Introducer 21 CFR §876.5090 Date Prepared: December 26, 2018
| Submitted By: | Traditional 510(k) Premarket Notification |
|---|---|
| Submission: | Cook Incorporated |
| Applicant: | Carly Powell |
| Primary Contact: | Karthik Pillai, Ph.D. |
| Secondary Contact: | Cook Incorporated |
| Applicant Address: | 750 Daniels Way |
| Contact Phone Number: | |
| Contact Fax Number: | (812) 332-0281 |
| Device Information: | |
| Trade Names: | One-Step Suprapubic Introducer |
| Common Name: | Catheter, Suprapubic |
| Classification Name: | Suprapubic urological catheter and accessories |
| Regulation: | 21 CFR §876.5090 |
| Product Code: | KOB |
| Review Panel: | Class II, Gastroenterology/Urology |
Predicate device:
The One-Step Suprapubic Introducer is substantially equivalent to the following device:
- Predicate device: Supra-Foley Suprapubic Catheter Introducer cleared under K884061
Device Description:
The One-Step Suprapubic Introducer is comprised of a stainless steel trocar stylet needle and a dilator with a peel-away sheath. The trocar stylet needle is 20 centimeters (cm) long with a trocar beveled tip at the distal end of the device. The dilator is 14-22 French (Fr) and 18-19 cm in length. The peel-away sheath is 14-22 Fr and 17 cm in length. The three components are designed to fit together to form a single assembly.
4
Intended Use:
The One-Step Suprapubic Introducer is intended for introducing a drainage catheter suprapubically into the bladder.
Comparison to Predicate:
The subject and predicate device, Supra-Foley Suprapubic Catheter Introducer, are substantially equivalent in that these devices are similar in indications for use and method of placement. Additionally, the subject device has a similar design and technological characteristics as the predicate device. The differences between the subject device and the predicate device include materials, dimensions, and components. Characteristics of the subject device that differ from the predicate device are supported by testing and do not raise any new questions of safety and effectiveness.
Performance Data:
The subject device, the One-Step Suprapubic Introducer, was subjected to applicable testing to assure reliable design and performance under the testing parameters. The following tests have been conducted to ensure reliable design and performance under the specified testing parameters:
- . Radiopacity Testing
- Peel-Away Shaft Tensile Test ●
- Dilator Shaft Tensile Test ●
- Peel Force ●
- Rollback Testing ●
- Dilator Hub-to-Shaft Tensile Test .
- Dimensional Testing ●
- Biocompatibility Testing shows that the subject device conforms to the ● biocompatibility requirements based on its intended use. All evaluation criteria were met. The following biological effects were evaluated:
- o Cytotoxicity
- Sensitization o
- Irritation/Intracutaneous Reactivity o
- Acute Systemic Toxicity O
- Sterilization ●
- Package integrity and stability
- Shelf-life ●
5
All predetermined acceptance criteria were met.
Conclusion:
The data included in this submission indicate that the subject device does not raise new questions of safety or effectiveness compared to the predicate device, the Supra-Foley Suprapubic Catheter Introducer (K884061), which supports a determination of substantial equivalence.